经口内镜下肌切开术作为食管动力障碍再治疗:西方队列倾向匹配分析
该回顾性队列纳入2012年3月至2024年3月因食管动力障碍行POEM的564例患者,其中108例(19.1%)有既往治疗失败史。中位随访36个月,PTF组临床失败率显著高于初治组(21.3% vs 10.7%,P<.01);倾向匹配后PTF与临床失败显著相关(HR 2.20,P=.04),但两组GERD相关结局无显著差异。
要点
- POEM对既往治疗失败的食管动力障碍患者可行、安全且有效。
- PTF患者长期临床失败率高于初治患者,需更密切监测。
- PTF与临床失败独立相关(HR 2.20),但GERD相关结局无显著差异。
核心结论
- POEM对既往治疗失败的食管动力障碍患者总体可行、安全且有效。
- 但PTF患者长期临床失败率显著高于初治患者,强调需更密切监测并可能加强干预。
研究设计与样本
- 回顾性评估2012年3月至2024年3月连续接受POEM的食管动力障碍患者。
- 纳入随访至少6个月者,共564例,中位年龄57岁,57.3%男性,中位随访36个月。
- PTF定义为既往接受过肉毒毒素注射、Heller肌切开术、POEM或气动球囊扩张。
- 采用1:1倾向评分匹配,匹配后分析130例(每组65例)。
- 使用Kaplan-Meier曲线和Cox比例风险回归识别临床失败预测因素。
主要发现
- 564例中108例(19.1%)有既往治疗史。
- PTF组临床失败率显著高于初治组(21.3% vs 10.7%;P<.01)。
- 匹配后PTF与临床失败显著相关(风险比2.20;P=.04)。
- 两组临床反流无统计学显著差异(比值比1.77;P=.193)。
- ≥B级食管炎(比值比1.52;P=.350)和酸暴露时间≥6%(比值比1.72;P=.163)均无统计学显著差异。
关键数值与推荐
- 临床失败定义为Eckardt评分>3。
- PTF定义包括既往肉毒毒素注射、Heller肌切开术、POEM和气动球囊扩张。
- 随访至少6个月为纳入标准。
临床怎么用
- POEM可用于既往治疗失败的食管动力障碍患者的再治疗。
- 对PTF患者应加强术后长期监测,警惕临床失败风险升高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: The long-term outcomes of peroral endoscopic myotomy (POEM) in patients with prior treatment failure (PTF) remain uncertain. This study aimed to assess long-term outcomes in patients with PTF compared with treatment-naive patients. METHODS: Consecutive patients who underwent POEM for esophageal motility disorders between March 2012 and March 2024 were retrospectively evaluated. Patients with at least 6 months of follow-up were included. Patients with PTF were defined as those who underwent previous treatments, including botulinum toxin injection, Heller myotomy, POEM, and pneumatic balloon dilation. Clinical failure (Eckardt score >3) and GERD-related outcomes were assessed. A 1:1 propensity score matching was performed. Kaplan-Meier curves and Cox proportional hazards regression were used to identify predictors of clinical failure. RESULTS: Among the 564 patients who underwent POEM (median age, 57; 57.3% male; median follow-up, 36 months), 108 (19.1%) had undergone prior treatments. Patients with PTF had a significantly higher rate of clinical failure than treatment-naive group (21.3% vs 10.7%; P < .01). After matching, 130 patients (65 for each group) were analyzed. PTF was significantly associated with clinical failure (hazard ratio, 2.20; P = .04). No statistically significant difference was observed between groups in terms of clinical reflux (odds ratio [OR], 1.77; P = .193), ≥B grade esophagitis (OR, 1.52; P = .350), and acid exposure time ≥6% (OR, 1.72; P = .163). CONCLUSIONS: Overall, POEM is feasible, safe, and effective for patients with PTF. However, the long-term clinical failure rate is higher than that in treatment-naive patients, emphasizing the need for closer monitoring and possibly enhanced interventions for these patients.
引用
- Alfarone L, de Sire R, Massimi D, et al. Peroral endoscopic myotomy as retreatment for esophageal motility disorders: a propensity-matched analysis from a Western cohort. Gastrointest Endosc. 2026. PMID: 42349761. doi:10.1016/j.gie.2026.06.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。